Understanding the Impact of Mpox on Sexual Health Clinical Services: A National Knowledge, Attitudes, and Practices Survey - United States, 2022

Sara L. Schubert, Kathryn Miele, Laura A.S. Quilter, Christine Agnew-Brune, Alexandra Coor, Rachel Kachur, Felicia Lewis, Kevin L. Ard, Karen Wendel, Teri Anderson, Gowri Nagendra, Erin Tromble, Elizabeth Gilliams, Matthew M. Hamill, Kelly Johnson, Christine Johnston, Destiny Kelley, Philana Liang, Candice McNeil, Kathrine MeyersNatalie Neu, Tamara Ooms, Hilary Reno, Nicholas Jay Van Wagoner, Jason Zucker

Research output: Contribution to journalArticlepeer-review


Background During the 2022 mpox outbreak, most cases were associated with sexual contact, and many people with mpox sought care from sexual health clinics and programs. The National Network of STD Clinical Prevention Training Centers, in partnership with the Centers for Disease Control and Prevention, conducted a survey of US sexual health clinics and programs to assess knowledge, practices, and experiences around mpox to inform a future public health response. Methods Between August 31 and September 13, 2022, the National Network of STD Clinical Prevention Training Centers facilitated a web-based survey. Descriptive statistics were generated in R. Results Among 168 responses by clinicians (n = 131, 78%) and program staff (n = 37, 22%), more than half (51%) reported at least somewhat significant mpox-related clinical disruptions including burdensome paperwork requirements for mpox testing (40%) and tecovirimat use (88%). Long clinic visits (51%) added additional burden, and the median mpox-related visit lasted 1 hour. Few clinicians felt comfortable with advanced pain management, and clinicians felt most uninformed about preexposure (19%) and postexposure (24%) prophylaxis. Of 89 respondents involved in vaccination, 61% reported using equity strategies; however, accounts of these strategies revealed a focus on guideline or risk factor-based screenings instead of equity activities. Conclusions These findings highlight the substantial impact of the 2022 mpox outbreak on sexual health care in the United States. Critical gaps and barriers were identified that may inform additional mpox training and technical assistance, including challenges with testing, diagnosis, and management as well as a disconnect between programs' stated goal of equity and operationalization of strategies to achieve equity.

Original languageEnglish
Pages (from-to)38-46
Number of pages9
JournalSexually transmitted diseases
Issue number1
StatePublished - Jan 1 2024


Dive into the research topics of 'Understanding the Impact of Mpox on Sexual Health Clinical Services: A National Knowledge, Attitudes, and Practices Survey - United States, 2022'. Together they form a unique fingerprint.

Cite this